angiotensin ii has been researched along with cysteine in 24 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 8 (33.33) | 18.7374 |
| 1990's | 1 (4.17) | 18.2507 |
| 2000's | 5 (20.83) | 29.6817 |
| 2010's | 6 (25.00) | 24.3611 |
| 2020's | 4 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Auerswald, W; Doleschel, W | 1 |
| Potter, DE; Walaszek, EJ | 1 |
| Douglas, JR; Jaffe, BM; Johnson, EM; Marshall, GR; Needleman, P | 1 |
| Toda, N | 1 |
| Fleisch, JH; Krzan, MC; Titus, E | 1 |
| Douglas, JR; Marshall, GR; Needleman, P | 1 |
| Möschler, HJ; Schwyzer, R | 1 |
| Furukawa, T; Morishita, H; Ono, N; Tokunaga, T | 1 |
| Graves, DJ; Huang, CY; Yuan, CJ | 1 |
| Gopalakrishnan, V; Liu, P; Misurski, DA | 1 |
| Auger-Messier, M; Escher, E; Guillemette, G; Lanctot, PM; Leclerc, PC; Leduc, R | 1 |
| Chataigneau, M; Diallo, AS; Etienne-Selloum, N; Geffard, M; Muller, B; Sarr, M; Schini-Kerth, VB; Schott, C; Stoclet, JC | 1 |
| Bibert, S; Chia, KK; Cornelius, F; Figtree, GA; Garcia, A; Geering, K; Hamilton, EJ; Liu, CC; Rasmussen, HH; White, CN | 1 |
| Corrêa, SA; Martin, RP; Nakaie, CR; Oliveira, L; Oliveira, SM; Pacheco, NA; Rodrigues, ES; Shimuta, SI | 1 |
| Chakrabarti, S; Davidge, ST; Lekontseva, O; Peters, A | 1 |
| Escher, E; Guillemette, G; Holleran, BJ; Lavigne, P; Leduc, R; Yan, L | 1 |
| Kitajima, N; Kurose, H; Nakaya, M; Nishida, M; Saiki, S | 1 |
| Allahdadi, KJ; Choi, H; Tostes, RC; Webb, RC | 1 |
| Baskaran, P; Beuve, A; Couloubaly, S; Crassous, PA; Durán, WN; Fioramonti, X; Huang, C; Kim, DD; Papapetropoulos, A; Zhou, Z | 1 |
| Boylston, J; Casin, KM; Fillmore, N; Kohr, MJ; Liu, C; Ma, H; Murphy, E; Noguchi, A; Sinha, P; Sun, J; Wang, N; Zhou, G | 1 |
| Chen, H; Hu, P; Liu, J; Que, Y; Shu, X; Tong, X; Wang, L; Wang, S; Xiong, R | 1 |
| Ao-Ieong, WS; Chen, CH; Ho, HH; Jiang, WC; Layne, MD; Orekhov, AN; Sobenin, IA; Wang, J; Yet, SF | 1 |
| Huang, C; Luo, H; Luo, Y; Wu, H; Zhang, Y | 1 |
| Alvizo-Paez, ER; Choi, H; Derda, R; Ekanayake, AI; Fernandez, KX; John, JD; Kalhor-Monfared, S; Kang, H; Kelich, P; Kharchenko, S; Kirberger, SE; Li, J; Lin, YS; Macauley, MS; Miao, J; Nuss, JM; Pomerantz, WCK; Qiu, R; Sarkar, S; Vederas, JC; Vukovic, L; Wong, JYK | 1 |
2 review(s) available for angiotensin ii and cysteine
| Article | Year |
|---|---|
Central and peripheral effects of sulfur amino acids: antagonism against central effect of angiotensin.
Topics: Amino Acids, Sulfur; Angiotensin II; Animals; Blood Pressure; Calcium; Cysteic Acid; Cysteine; Electric Stimulation; gamma-Aminobutyric Acid; Methionine; Muscle Contraction; Renin-Angiotensin System; Sympathetic Nervous System; Synaptic Transmission; Taurine | 1983 |
Regulation of Angiotensin II receptor signaling by cysteine modification of NF-κB.
Topics: Angiotensin II; Animals; Cysteine; Fibroblasts; Gene Expression Regulation; Humans; Nitric Oxide; Nitric Oxide Synthase Type II; Oxidation-Reduction; Rats; Reactive Oxygen Species; Receptors, Angiotensin; Signal Transduction; Transcription Factor RelA; Up-Regulation | 2011 |
22 other study(ies) available for angiotensin ii and cysteine
| Article | Year |
|---|---|
On the potentiation of kinins by sulfhydrylic compounds.
Topics: Angiotensin II; Animals; beta-Aminoethyl Isothiourea; Bradykinin; Cysteamine; Cysteine; Dimercaprol; Drug Synergism; Eledoisin; Guinea Pigs; Ileum; In Vitro Techniques; Kallidin; Mercaptoethanol; Muscle Contraction | 1967 |
Potentiation of the bradykinin response by cysteine: mechanism of action.
Topics: Acetylcholine; Aminobutyrates; Angiotensin II; Animals; Atropine; Bradykinin; Cysteine; Drug Antagonism; Drug Synergism; Eledoisin; Guinea Pigs; Hydrogen-Ion Concentration; Ileum; In Vitro Techniques; Morphine; Muscle Contraction; Muscle, Smooth; Nerve Endings; Spermine; Stimulation, Chemical; Strychnine; Temperature; Tetrodotoxin | 1972 |
Stimulation of splenic prostaglandin release by angiotensin and specific inhibition by cysteine 8-AII.
Topics: Angiotensin II; Animals; Biological Assay; Chickens; Colon; Cysteine; Depression, Chemical; Female; Indomethacin; Perfusion; Prostaglandins; Rabbits; Rats; Rectum; Spleen; Stimulation, Chemical; Stomach | 1973 |
Influence of cadmium ions on contractile response of isolated aortas to stimulatory agents.
Topics: Acetates; Angiotensin II; Animals; Aorta, Thoracic; Barium; Cadmium; Calcium; Cysteine; Depression, Chemical; Female; Glycols; Histamine; In Vitro Techniques; Male; Membrane Potentials; Muscle Contraction; Muscle, Smooth; Norepinephrine; Potassium; Rabbits | 1973 |
Pharmacologic receptor activity of rabbit aorta. Effect of dithiothreitol and N-ethylmaleimide.
Topics: Amine Oxidase (Copper-Containing); Angiotensin II; Animals; Aorta; Cysteine; Cystine; Dithiothreitol; Erythritol; Ethylmaleimide; Histamine; In Vitro Techniques; Male; Methyltransferases; Muscle Contraction; Muscle, Smooth; Norepinephrine; Phentolamine; Potassium Chloride; Rabbits; Receptors, Drug; Serotonin | 1973 |
Prostaglandin release from vasculature by angiotensin II: dissociation from lipolysis.
Topics: Adipose Tissue; Adrenocorticotropic Hormone; Angiotensin II; Animals; Blood Pressure; Cysteine; Epididymis; Epinephrine; Glycerol; In Vitro Techniques; Lipid Metabolism; Male; Perfusion; Prostaglandins; Rabbits; Rats; Spleen; Vasoconstrictor Agents | 1973 |
Hormone-receptor interations. Synthesis of a biologically active cysteinyl-angiotensin derivative and its use for the preparation of spin-labelled and polymer-supported molecules.
Topics: Angiotensin II; Animals; Cysteine; Polymers; Rats; Spin Labels | 1974 |
Oxidation and site-directed mutagenesis of the sulfhydryl groups of a truncated gamma catalytic subunit of phosphorylase kinase. Functional and structural effects.
Topics: Amino Acid Sequence; Angiotensin II; Catalysis; Copper; Cysteine; Kinetics; Molecular Sequence Data; Mutagenesis, Site-Directed; Oxidation-Reduction; Phosphorylase Kinase; Phosphorylation; Sulfhydryl Compounds | 1994 |
Cysteinyl leukotriene-dependent [Ca2+]i responses to angiotensin II in cardiomyocytes.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Animals, Newborn; Arginine Vasopressin; Benzoquinones; Calcium; Cysteine; Endothelin-1; Enzyme Inhibitors; Fluorescent Dyes; Fura-2; Heart; Imidazoles; Inositol 1,4,5-Trisphosphate; Leukotriene C4; Leukotriene D4; Leukotrienes; Lipoxygenase Inhibitors; Losartan; Myocardium; Propionates; Pyridines; Quinolines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Spectrometry, Fluorescence | 2003 |
S-nitrosylation of cysteine 289 of the AT1 receptor decreases its binding affinity for angiotensin II.
Topics: Amino Acid Substitution; Angiotensin II; Cysteine; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Guanylate Cyclase; Humans; Nitric Oxide Donors; Nitroprusside; Protein Binding; Receptor, Angiotensin, Type 1 | 2006 |
Targeted and persistent effects of NO mediated by S-nitrosation of tissue thiols in arteries with endothelial dysfunction.
Topics: Angiotensin II; Animals; Anions; Cysteine; Endothelium, Vascular; Male; Models, Biological; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitrogen; Oxidative Stress; Rats; Rats, Wistar; Reactive Oxygen Species; Sulfhydryl Compounds | 2007 |
Reversible oxidative modification: a key mechanism of Na+-K+ pump regulation.
Topics: Adenosine Triphosphatases; Angiotensin II; Animals; Cation Transport Proteins; Cell Adhesion Molecules, Neuronal; Cysteine; Glutaredoxins; Glutathione; Humans; Kidney; Kinetics; Male; Mutation; Myocytes, Cardiac; NADPH Oxidases; Oocytes; Oxidation-Reduction; Paraquat; Peroxynitrous Acid; Protein Conformation; Protein Kinase C; Protein Processing, Post-Translational; Rabbits; Sheep; Signal Transduction; Sodium-Potassium-Exchanging ATPase; Structure-Activity Relationship; Superoxide Dismutase; Swine; Xenopus laevis | 2009 |
Distinct binding mode of 125I-AngII to AT1 receptor without the Cys18-Cys274 disulfide bridge.
Topics: Angiotensin II; Animals; Binding, Competitive; CHO Cells; Cricetinae; Cricetulus; Cysteine; Iodine Radioisotopes; Protein Binding; Radioligand Assay; Receptor, Angiotensin, Type 1 | 2009 |
17beta-Estradiol induces protein S-nitrosylation in the endothelium.
Topics: Angiotensin II; Animals; Aorta; Cells, Cultured; Cysteine; Disease Models, Animal; Endothelial Cells; Estradiol; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; Humans; Nitric Oxide; Nitric Oxide Synthase Type I; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrogen; Rats; Rats, Sprague-Dawley; Umbilical Veins; Vasoconstrictor Agents | 2010 |
Analysis of transmembrane domains 1 and 4 of the human angiotensin II AT1 receptor by cysteine-scanning mutagenesis.
Topics: Angiotensin II; Animals; Arginine; Binding Sites; Chlorocebus aethiops; COS Cells; Cysteine; Ethyl Methanesulfonate; Humans; Indicators and Reagents; Membrane Proteins; Mutagenesis, Site-Directed; Protein Structure, Tertiary; Receptor, Angiotensin, Type 1 | 2010 |
Augmented S-nitrosylation contributes to impaired relaxation in angiotensin II hypertensive mouse aorta: role of thioredoxin reductase.
Topics: Acetylcholine; Angiotensin II; Animals; Aorta, Thoracic; Cyclic GMP; Cysteine; Dinitrochlorobenzene; Disease Models, Animal; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Male; Mice; Mice, Inbred C57BL; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Donors; Phenylephrine; S-Nitrosothiols; Thioredoxin-Disulfide Reductase; Vascular Resistance; Vasoconstrictor Agents; Vasodilator Agents | 2011 |
Soluble guanylyl cyclase is a target of angiotensin II-induced nitrosative stress in a hypertensive rat model.
Topics: Angiotensin II; Animals; Arterioles; Blood Pressure; Cell Line; Cyclic GMP; Cysteine; Disease Models, Animal; Enzyme Activation; Guanylate Cyclase; Hypertension; Male; Muscle, Smooth, Vascular; Mutation; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Donors; Nitrosation; Oxidative Stress; Protein Processing, Post-Translational; Rats; Rats, Sprague-Dawley; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Time Factors; Transfection; Vascular Resistance; Vasodilation | 2012 |
A knock-in mutation at cysteine 144 of TRIM72 is cardioprotective and reduces myocardial TRIM72 release.
Topics: Angiotensin II; Animals; Cardiomegaly; Coronary Artery Disease; Cysteine; Disease Models, Animal; Gene Knock-In Techniques; Insulin Resistance; Membrane Proteins; Mice, Inbred C57BL; Mice, Mutant Strains; Mutation; Myocardial Reperfusion Injury; Myocardium | 2019 |
Inactivation of cysteine 674 in the SERCA2 accelerates experimental aortic aneurysm.
Topics: Angiotensin II; Animals; Aortic Aneurysm; Calcineurin; Cholesterol; Cysteine; Down-Regulation; Humans; Mice, Inbred C57BL; Myocytes, Smooth Muscle; NF-kappa B; NFATC Transcription Factors; Nuclear Proteins; Osteopontin; Oxidation-Reduction; Phenotype; Receptors, LDL; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Signal Transduction; Trans-Activators; Triglycerides; Up-Regulation | 2020 |
Cysteine-rich protein 2 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation in mice.
Topics: Angiotensin II; Animals; Aortic Aneurysm, Abdominal; Apolipoproteins E; Collagen; Cysteine; Disease Models, Animal; Matrix Metalloproteinase 2; Mice; Mice, Inbred C57BL; Mice, Knockout; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle | 2022 |
Activating transcription factor 3 inhibits angiotensin II‑induced cardiomyocyte viability and fibrosis by activating the transcription of cysteine‑rich angiogenic protein 61.
Topics: Activating Transcription Factor 3; Angiogenic Proteins; Angiotensin II; Cyclic AMP Response Element-Binding Protein; Cysteine; Cysteine-Rich Protein 61; Fibrosis; Humans; Myocytes, Cardiac; RNA, Messenger; Transforming Growth Factor beta | 2022 |
Genetically encoded discovery of perfluoroaryl macrocycles that bind to albumin and exhibit extended circulation in vivo.
Topics: Albumins; Angiotensin II; Animals; Apelin; Cysteine; Humans; Mice; Serum Albumin, Human; Sulfides | 2023 |